Reported 2 days ago
UnitedHealth Group has faced a challenging period recently with declining earnings, changes in leadership, and negative publicity. The stock has fallen over 40% this year, hitting five-year lows. Despite these issues, management's insider buying suggests confidence in the company's recovery, and analysts believe the current low valuation presents a buying opportunity for long-term investors, although caution is advised given the company's recent turbulence.
Source: YAHOO